What is the recommended dose of cefdinir (Cefdinir) for a 3-year-old child with acute otitis media (ear infection)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cefdinir Dosing for a 3-Year-Old with Acute Otitis Media

For a 3-year-old child with acute otitis media, the recommended dose of cefdinir is 14 mg/kg per day, given either as a single daily dose or divided into two doses (7 mg/kg twice daily) for 5-10 days. 1

Dosing Options

The FDA-approved dosing for cefdinir in pediatric patients with acute otitis media provides two administration options:

  • 14 mg/kg once daily for 10 days
  • 7 mg/kg twice daily for 5-10 days 1

For a typical 3-year-old weighing approximately 14-16 kg:

  • Once-daily dosing: ~200-225 mg once daily
  • Twice-daily dosing: ~100-112 mg twice daily

Formulation and Administration

Cefdinir is available as an oral suspension in two concentrations:

  • 125 mg/5 mL
  • 250 mg/5 mL 1

The medication can be administered without regard to meals, which improves compliance in young children. 1

Clinical Evidence and Guidelines

The American Academy of Pediatrics recommends cefdinir as an alternative treatment for acute otitis media in children with penicillin allergy. 2 It is particularly preferred because of high patient acceptance, likely due to its palatable taste compared to other antibiotics. 2

While high-dose amoxicillin (80-90 mg/kg/day) remains the first-line treatment for uncomplicated acute otitis media, cefdinir is an appropriate alternative when:

  • The child has a penicillin allergy (non-Type I/non-anaphylactic)
  • The child cannot tolerate amoxicillin
  • There is concern about beta-lactamase producing organisms 2, 3

Efficacy Considerations

It's important to note that comparative studies have shown that high-dose amoxicillin/clavulanate (90 mg/kg/day of amoxicillin component) for 10 days has better clinical cure rates (86.5%) than cefdinir (71.0%) for 5 days in young children with acute otitis media. 4

Research has also shown that cefdinir's efficacy against penicillin-resistant Streptococcus pneumoniae is limited, with eradication rates of only 43% for penicillin-resistant strains compared to 91% for penicillin-susceptible strains. 5

Duration of Treatment

The FDA-approved duration for cefdinir treatment in acute otitis media is 5-10 days. 1 A 5-day course has been shown to be as effective as longer courses of other cephalosporins for uncomplicated acute otitis media. 6

Common Side Effects and Monitoring

The most common adverse effect is diarrhea, which occurs in approximately 8% of children. 6 Parents should be advised to complete the full course of antibiotics even if symptoms improve before completion.

Follow-up Recommendations

If no improvement is seen after 48-72 hours of therapy, the child should be reevaluated, and an alternative antibiotic should be considered. 2 Persistent middle ear effusion after treatment is common and does not necessarily indicate treatment failure, as 60-70% of children will have middle ear effusion at 2 weeks after successful treatment. 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.